BROMOCRIPTINE

Course overview

BROMOCRIPTINE IS A MEDICATION CURRENTLY USED IN THE MANAGEMENT AND TREATMENT OF TYPE II DIABETES MELLITUS. IT IS AN ERGOT ALKALOID DERIVATIVE IN THE DOPAMINE D2 AGONIST CLASS OF DRUGS. THIS ACTIVITY WILL REVIEW THE INDICATIONS, CONTRAINDICATIONS, AND MECHANISM OF ACTION FOR BROMOCRIPTINE AS A VALUABLE AGENT IN THE MANAGEMENT FOR TYPE II DIABETES MELLITUS, AS WELL AS ITS MORE TRADITIONAL USES IN PARKINSON DISEASE, ACROMEGALY, AND PITUITARY PROLACTINOMAS. FURTHER, THROUGHOUT THIS ACTIVITY, WE WILL HIGHLIGHT THE MECHANISM OF ACTION, ADVERSE EVENT PROFILE, AND OTHER KEY FACTORS THAT ARE PERTINENT FOR ALL MEMBERS OF THE INTER-PROFESSIONAL HEALTHCARE TEAM IN THE MANAGEMENT OF PATIENTS WITH TYPE II DIABETES MELLITUS, PARKINSON DISEASE, ACROMEGALY, AND PITUITARY PROLACTINOMAS USING BROMOCRIPTINE.